BeiGene Management
Management criteria checks 2/4
BeiGene's CEO is John Oyler, appointed in Jan 2010, has a tenure of 14.67 years. total yearly compensation is $18.93M, comprised of 4.6% salary and 95.4% bonuses, including company stock and options. directly owns 3.91% of the company’s shares, worth HK$6.69B. The average tenure of the management team and the board of directors is 2.4 years and 4.7 years respectively.
Key information
John Oyler
Chief executive officer
US$18.9m
Total compensation
| CEO salary percentage | 4.6% |
| CEO tenure | 14.7yrs |
| CEO ownership | 3.9% |
| Management average tenure | 2.4yrs |
| Board average tenure | 4.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$524m |
| Mar 31 2024 | n/a | n/a | -US$784m |
| Dec 31 2023 | US$19m | US$871k | -US$882m |
| Sep 30 2023 | n/a | n/a | -US$959m |
| Jun 30 2023 | n/a | n/a | -US$2b |
| Mar 31 2023 | n/a | n/a | -US$2b |
| Dec 31 2022 | US$18m | US$800k | -US$2b |
| Sep 30 2022 | n/a | n/a | -US$2b |
| Jun 30 2022 | n/a | n/a | -US$2b |
| Mar 31 2022 | n/a | n/a | -US$2b |
| Dec 31 2021 | US$17m | US$740k | -US$1b |
| Sep 30 2021 | n/a | n/a | -US$1b |
| Jun 30 2021 | n/a | n/a | -US$1b |
| Mar 31 2021 | n/a | n/a | -US$1b |
| Dec 31 2020 | US$14m | US$696k | -US$2b |
| Sep 30 2020 | n/a | n/a | -US$2b |
| Jun 30 2020 | n/a | n/a | -US$1b |
| Mar 31 2020 | n/a | n/a | -US$1b |
| Dec 31 2019 | US$13m | US$675k | -US$949m |
| Sep 30 2019 | n/a | n/a | -US$829m |
| Jun 30 2019 | n/a | n/a | -US$665m |
| Mar 31 2019 | n/a | n/a | -US$737m |
| Dec 31 2018 | US$28m | US$650k | -US$674m |
| Sep 30 2018 | n/a | n/a | -US$505m |
| Jun 30 2018 | n/a | n/a | -US$243m |
| Mar 31 2018 | n/a | n/a | -US$147m |
| Dec 31 2017 | US$10m | US$515k | -US$93m |
Compensation vs Market: John's total compensation ($USD18.93M) is above average for companies of similar size in the Hong Kong market ($USD993.98K).
Compensation vs Earnings: John's compensation has increased whilst the company is unprofitable.
CEO
John Oyler (56 yo)
14.7yrs
Tenure
US$18,925,730
Compensation
Mr. John V. Oyler Co-Founded BeiGene, Ltd. and has been its Chief Executive Officer since 2010. Mr. Oyler Co-founded BioDuro, LLC and served as its Chief Executive Officer and President from 2005 to 2009....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 14.7yrs | US$18.93m | 3.91% $ 6.7b | |
| President & COO | 6.3yrs | US$11.00m | 0.055% $ 94.9m | |
| Co-Chairman of Scientific Advisory Board & Non-Executive Director and Co-Founder | 14.7yrs | US$4.42m | 0.82% $ 1.4b | |
| General Counsel & Senior VP | 2.2yrs | US$4.05m | 0.018% $ 31.3m | |
| Global Head of R&D | no data | US$7.32m | 0.13% $ 220.5m | |
| CFO & Principal Financial Officer | less than a year | no data | no data | |
| VP & Chief Accounting Officer | less than a year | no data | 0.0033% $ 5.7m | |
| Head of Investor Relations | no data | no data | no data | |
| Chief Compliance Officer | less than a year | no data | no data | |
| Senior VP & Head of Public Affairs - Greater China | 3.7yrs | no data | no data | |
| Senior Vice President of Strategy & Corporate Development | 1.6yrs | no data | no data | |
| Senior VP & Chief Medical Officer for Solid Tumors | 2.6yrs | no data | no data |
2.4yrs
Average Tenure
53.5yo
Average Age
Experienced Management: 6160's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.9yrs | US$18.93m | 3.91% $ 6.7b | |
| Co-Chairman of Scientific Advisory Board & Non-Executive Director and Co-Founder | 8.6yrs | US$4.42m | 0.82% $ 1.4b | |
| Acting Head of Medicinal Chemistry & Member of Scientific Advisory Board | 3.4yrs | no data | no data | |
| Independent Non-Executive Director & Member of the Scientific Advisory Committee | 9.4yrs | US$481.92k | 0.0034% $ 5.8m | |
| Independent Non-Executive Director | 11.6yrs | US$480.80k | 0.20% $ 334.2m | |
| Independent Non-Executive Director & Member of Scientific Advisory Committee | 4.1yrs | US$501.55k | 0.0022% $ 3.7m | |
| Independent Non-Executive Director | 4.7yrs | US$513.15k | 0.0027% $ 4.6m | |
| Co-Chairman of Scientific Advisory Committee & Independent Non-Executive Director | 2.6yrs | US$491.67k | 0.0021% $ 3.7m | |
| Independent Non-Executive Director | less than a year | no data | 0% $ 0 | |
| Independent Lead Director | 9.9yrs | US$487.05k | 0.0034% $ 5.8m | |
| Member of Scientific Advisory Board & Independent Non-Executive Director | 2.6yrs | US$510.55k | 0.0021% $ 3.7m |
4.7yrs
Average Tenure
65yo
Average Age
Experienced Board: 6160's board of directors are considered experienced (4.7 years average tenure).